These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15817265)

  • 21. Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector.
    Chtarto A; Yang X; Bockstael O; Melas C; Blum D; Lehtonen E; Abeloos L; Jaspar JM; Levivier M; Brotchi J; Velu T; Tenenbaum L
    Exp Neurol; 2007 Mar; 204(1):387-99. PubMed ID: 17223106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation.
    Zourlidou A; Gidalevitz T; Kristiansen M; Landles C; Woodman B; Wells DJ; Latchman DS; de Belleroche J; Tabrizi SJ; Morimoto RI; Bates GP
    Hum Mol Genet; 2007 May; 16(9):1078-90. PubMed ID: 17360721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopaminergic trophism after intrastriatal injection of lentivirus-transferred GDNF in Parkinson rat model.
    Sun B; Hui GZ; Guo LH; Reiser J
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):937-40. PubMed ID: 14515213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model.
    Chou SY; Lee YC; Chen HM; Chiang MC; Lai HL; Chang HH; Wu YC; Sun CN; Chien CL; Lin YS; Wang SC; Tung YY; Chang C; Chern Y
    J Neurochem; 2005 Apr; 93(2):310-20. PubMed ID: 15816854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease.
    Sajadi A; Bensadoun JC; Schneider BL; Lo Bianco C; Aebischer P
    Neurobiol Dis; 2006 Apr; 22(1):119-29. PubMed ID: 16300956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.
    McBride JL; Ramaswamy S; Gasmi M; Bartus RT; Herzog CD; Brandon EP; Zhou L; Pitzer MR; Berry-Kravis EM; Kordower JH
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9345-50. PubMed ID: 16751280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment.
    Rebec GV; Conroy SK; Barton SJ
    Neuroscience; 2006; 137(1):327-36. PubMed ID: 16257492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease.
    Kells AP; Fong DM; Dragunow M; During MJ; Young D; Connor B
    Mol Ther; 2004 May; 9(5):682-8. PubMed ID: 15120329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ORMOSIL nanoparticles as a non-viral gene delivery vector for modeling polyglutamine induced brain pathology.
    Klejbor I; Stachowiak EK; Bharali DJ; Roy I; Spodnik I; Morys J; Bergey EJ; Prasad PN; Stachowiak MK
    J Neurosci Methods; 2007 Sep; 165(2):230-43. PubMed ID: 17655935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploratory activity and fear conditioning abnormalities develop early in R6/2 Huntington's disease transgenic mice.
    Bolivar VJ; Manley K; Messer A
    Behav Neurosci; 2003 Dec; 117(6):1233-42. PubMed ID: 14674843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue transglutaminase contributes to disease progression in the R6/2 Huntington's disease mouse model via aggregate-independent mechanisms.
    Bailey CD; Johnson GV
    J Neurochem; 2005 Jan; 92(1):83-92. PubMed ID: 15606898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lentiviral-mediated gene transfer of brain-derived neurotrophic factor is neuroprotective in a mouse model of neonatal excitotoxic challenge.
    Bemelmans AP; Husson I; Jaquet M; Mallet J; Kosofsky BE; Gressens P
    J Neurosci Res; 2006 Jan; 83(1):50-60. PubMed ID: 16299771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutation.
    Wade A; Jacobs P; Morton AJ
    Brain Res; 2008 Jan; 1188():61-8. PubMed ID: 18062944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Construction of lentiviral vectors encoding GDNF and GDNF expression in human neural stem cells].
    Wang S; Ren P; Xie S; Zhu W; Wang Y; Guan Y; Zhang Y
    Sheng Wu Gong Cheng Xue Bao; 2008 Dec; 24(12):2061-7. PubMed ID: 19306576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Slowed progression in models of Huntington disease by adipose stem cell transplantation.
    Lee ST; Chu K; Jung KH; Im WS; Park JE; Lim HC; Won CH; Shin SH; Lee SK; Kim M; Roh JK
    Ann Neurol; 2009 Nov; 66(5):671-81. PubMed ID: 19938161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced activity of cortico-striatal fibres in the R6/2 mouse model of Huntington's disease.
    Traficante A; Riozzi B; Cannella M; Rampello L; Squitieri F; Battaglia G
    Neuroreport; 2007 Dec; 18(18):1997-2000. PubMed ID: 18007201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The transduction of neurotrophin-3/GDNF attenuates the SGNC damage in deaf mice].
    Chen XW; Li H; Cao KL; Wei CG; Jin X
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1517-20. PubMed ID: 14521734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanism of the neurotrophic effect of GDNF on DA neurons: role of protein kinase CK2.
    Chao CC; Chiang CH; Ma YL; Lee EH
    Neurobiol Aging; 2006 Jan; 27(1):105-18. PubMed ID: 16298246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease.
    Dey ND; Bombard MC; Roland BP; Davidson S; Lu M; Rossignol J; Sandstrom MI; Skeel RL; Lescaudron L; Dunbar GL
    Behav Brain Res; 2010 Dec; 214(2):193-200. PubMed ID: 20493905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6/2 mouse model of Huntington's disease.
    Samadi P; Boutet A; Rymar VV; Rawal K; Maheux J; Kvann JC; Tomaszewski M; Beaubien F; Cloutier JF; Levesque D; Sadikot AF
    Genes Brain Behav; 2013 Feb; 12(1):108-24. PubMed ID: 23006318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.